Oral Antidiabetic Drugs Market - Global Industry Analysis
Oral Antidiabetic Drugs Market By Drugs Class (Sulfonylureas (Glimepiride, Gliclazide, Glyburide, Others), Meglitinides, Repaglinide, Nateglinide, Biguanides (Metformin, Others), Alpha-glucosidase inhibitors (Acarbose, Voglibose, Others), Others, By Type (Type 1 Diabetes, Type 2 diabetes), By End User (Hospital, Pharmacy Store, Drug Store, Diabetics Treatment Centres, Others) - Global Industry Perspective, Comprehensive Analysis And Forecast, 2020 – 2028
Published Date: 18-Oct-2021Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-687
Status : Published
The global oral antidiabetic drugs market accounted for USD 43.01 Billion in 2020 and is expected to reach USD 66.30 Billion by 2028, growing at a CAGR of 5.6% from 2021 to 2028.